Does MONTELUKAST Cause Concomitant disease aggravated? 46 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 46 reports of Concomitant disease aggravated have been filed in association with MONTELUKAST (Montelukast). This represents 0.2% of all adverse event reports for MONTELUKAST.
46
Reports of Concomitant disease aggravated with MONTELUKAST
0.2%
of all MONTELUKAST reports
0
Deaths
11
Hospitalizations
How Dangerous Is Concomitant disease aggravated From MONTELUKAST?
Of the 46 reports, 11 (23.9%) required hospitalization, and 1 (2.2%) were considered life-threatening.
Is Concomitant disease aggravated Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MONTELUKAST. However, 46 reports have been filed with the FAERS database.
What Other Side Effects Does MONTELUKAST Cause?
Asthma (8,372)
Dyspnoea (6,354)
Wheezing (5,159)
Drug ineffective (3,539)
Cough (3,475)
Therapeutic product effect incomplete (3,352)
Anxiety (2,994)
Loss of personal independence in daily activities (2,736)
Sleep disorder due to a general medical condition (2,101)
Obstructive airways disorder (2,073)
What Other Drugs Cause Concomitant disease aggravated?
SACUBITRIL\VALSARTAN (533)
SECUKINUMAB (461)
FINGOLIMOD (425)
MACITENTAN (286)
OMALIZUMAB (186)
SELEXIPAG (166)
METHOTREXATE (150)
RUXOLITINIB (142)
OCTREOTIDE (125)
BOSENTAN (123)
Which MONTELUKAST Alternatives Have Lower Concomitant disease aggravated Risk?
MONTELUKAST vs MONTELUKAST\MONTELUKAST
MONTELUKAST vs MONTMORILLONITE
MONTELUKAST vs MORNIFLUMATE
MONTELUKAST vs MOROCTOCOG ALFA
MONTELUKAST vs MORPHINE